Wednesday, September 12, 2007

Latest FDA news on anemia drugs

From the Wall Street Journal article:
A Food and Drug Administration advisory committee stopped short of supporting a clear-cut new limit on kidney-failure patients' use of the blockbuster anemia drugs made by Amgen Inc. and Johnson & Johnson, but members split over what doses of the medications are appropriate.
Click here to access (sub. req.).

No comments: